A Randomized Controlled Trial for Prevention of Postoperative Nausea and Vomiting after Laparoscopic Sleeve Gastrectomy: Aprepitant/Dexamethasone vs. Mirtazapine/Dexamethasone

<div>Relative risk with 95% CI for A/D group vs. M/D group for complete response in the first 24 h after surgery; showing that the probability of complete response relative to the <i>D</i> group was in the M/D group close to that in the A/D group. A/D group: aprepitant/dexamethasone group, M/D group: mirtazapine/dexamethasone group, and <i>D</i> group: dexamethasone group.</div>

Anesthesiology Research and Practice

fig3

Figure 3

Figure 3: A Randomized Controlled Trial for Prevention of Postoperative Nausea and Vomiting after Laparoscopic Sleeve Gastrectomy: Aprepitant/Dexamethasone vs. Mirtazapine/Dexamethasone 

Figure 3 | A Randomized Controlled Trial for Prevention of Postoperative Nausea and Vomiting after Laparoscopic Sleeve Gastrectomy: Aprepitant/Dexamethasone vs. Mirtazapine/Dexamethasone 